SO
ALDX icon

STRS Ohio’s Aldeyra Therapeutics ALDX Stock Holding History

STRS Ohio’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-68,200
Closed -$115K – 2160
2026
Q1 		$115K Hold
68,200
– – ﹤0.01% 1720
2025
Q4 		$353K Sell
68,200
-17,500
-20% -$89.9K ﹤0.01% 1246
2025
Q3 		$447K Buy
85,700
+3,400
+4% +$17.7K ﹤0.01% 1154
2025
Q2 		$315K Buy
82,300
+5,800
+8% +$15K ﹤0.01% 1493
2025
Q1 		$440K Sell
76,500
-21,400
-22% -$127K ﹤0.01% 1259
2024
Q4 		$489K Hold
97,900
– – ﹤0.01% 1219
2024
Q3 		$528K Buy
97,900
+6,200
+7% +$29.5K ﹤0.01% 1236
2024
Q2 		$304K Buy
91,700
+9,400
+11% +$36.8K ﹤0.01% 1443
2024
Q1 		$269K Sell
82,300
-5,200
-6% -$17.1K ﹤0.01% 1473
2023
Q4 		$307K Buy
87,500
+63,900
+271% +$197K ﹤0.01% 1450
2023
Q3 		$157K Hold
23,600
– – ﹤0.01% 1630
2023
Q2 		$198K Buy
+23,600
New +$233K ﹤0.01% 1589
2020
Q2 		– Sell
-29,700
Closed -$73K – 2153
2020
Q1 		$73K Hold
29,700
– – ﹤0.01% 1729
2019
Q4 		$172K Hold
29,700
– – ﹤0.01% 1693
2019
Q3 		$156K Sell
29,700
-42,200
-59% -$227K ﹤0.01% 1694
2019
Q2 		$431K Buy
71,900
+5,000
+7% +$37.6K ﹤0.01% 1388
2019
Q1 		$604K Buy
66,900
+28,100
+72% +$239K ﹤0.01% 1137
2018
Q4 		$322K Buy
38,800
+34,100
+726% +$349K ﹤0.01% 1476
2018
Q3 		$64K Hold
4,700
– – ﹤0.01% 1917
2018
Q2 		$37K Buy
+4,700
New +$37.5K ﹤0.01% 2016

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

STRS Ohio's ALDX Position: Q2 2026 in Review

STRS Ohio sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 68,200 shares — an estimated $115K sold.

STRS Ohio first reported a position in ALDX in Q2 2018 and held it in 20 quarters. The position peaked at $604K in Q1 2019. 108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • STRS Ohio reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 68,200 Aldeyra Therapeutics shares in Q2 2026, an estimated $115K.
  • STRS Ohio first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 20 quarters.
  • STRS Ohio's Aldeyra Therapeutics position peaked at $604K in Q1 2019.
  • 108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.